Flyvax Overview

  • Founded
  • 2011
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Flyvax General Information


Developer of a vaccine for cattle to aid in control of the horn fly. The company's products include FlyVax, a veterinary vaccine based on recombinant protein technology, which inhibits the horn fly's ability to feed on cattle.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 201 East Jefferson Street
  • Suite 201
  • Louisville, KY 40202
  • United States
+1 (888) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Flyvax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jun-2015 00.00 Completed Out of Business
2. Early Stage VC (Series A) 06-Feb-2014 00.00 00.00 00.000 Completed Startup
1. Grant 10-May-2011 $787K Completed Startup
To view Flyvax’s complete valuation and funding history, request access »

Flyvax Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view Flyvax’s complete cap table history, request access »

Flyvax Executive Team (3)

Name Title Board Seat Contact Info
Jenny Corbin Co-Founder & Board Member
Larry Horn Co-Founder & Director
You’re viewing 2 of 3 executive team members. Get the full list »

Flyvax Board Members (5)

Name Representing Role Since
Butch Mercer Self Board Member 000 0000
Jenny Corbin Flyvax Co-Founder & Board Member 000 0000
Kent Van Kampen Ph.D Self Board Member 000 0000
Phoebe Wood Self Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »